Login / Signup
Flashback Foreword: Gefitinib in Non-Small-Cell Lung Cancer: The IDEAL 1 Trial.
Thomas Eldridge Stinchcombe
Published in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Keyphrases
</>
small cell lung cancer
phase iii
study protocol
epidermal growth factor receptor
phase ii
clinical trial
randomized controlled trial
open label